Traws Pharma launches at-the-market offering of up to $5.58 million in shares

• Traws Pharma set up an at-the-market equity program with Citizens JMP Securities to sell common stock.
• Program size capped at USD 50 million under the distribution agreement, subject to limits.
• Current “baby shelf” capacity limits sales under the prospectus supplement to up to USD 5.58 million.
• Shares will be sold from time to time through the agent under the company’s effective Form S-3 shelf registration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Traws Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-082649), on July 10, 2026, and is solely responsible for the information contained therein.